Published in Medicine and Law Weekly, February 19th, 2010
"We conducted two independent phase II clinical trials in small-cell lung cancer and non-small-cell lung cancer using bevacizumab in combination with chemotherapy and radiation. Both trials were intended to assess preliminary efficacy and safety outcomes. For the limited-stage small-cell lung cancer trial, 29 patients were enrolled beginning April 2006, and closed early due to...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medicine and Law Weekly